Kestra Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Kestra Advisory Services's VRTX Position: Q3 2026 in Review
Kestra Advisory Services increased its Vertex Pharmaceuticals (VRTX) stake by 46% in Q3 2026, buying an estimated $3.71M and bringing the position to 22,981 shares worth $12M. The position accounts for 0.03% of the portfolio, ranked #505.
Kestra Advisory Services first reported a position in VRTX in Q3 2020 and has held it in 25 quarters since. 1,786 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Kestra Advisory Services held 22,981 shares of Vertex Pharmaceuticals worth $12M as of Q3 2026.
- Kestra Advisory Services bought 7,249 Vertex Pharmaceuticals shares in Q3 2026, an estimated $3.71M.
- Vertex Pharmaceuticals made up 0.03% of Kestra Advisory Services's portfolio in Q3 2026, its #505 holding.
- Kestra Advisory Services first reported a position in Vertex Pharmaceuticals in Q3 2020 and has held it in 25 quarters since.
- 1,786 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.